Ocugen, Inc. (OCGN)
|52 Week Range||0.185-18.77|
|1y Target Est||-|
|Debt / Equity||15.83%||Neutral|
Upgrades & Downgrades
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocu...
Los Angeles, California--(Newsfile Corp. - June 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or "the Company") (NASDAQ: OCGN...
It's Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short. ...
Ocugen Inc. Set to Join Russell 3000® Index
MALVERN, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COV... ...
OCGN Stock Price Increased 2.12%: Why It Happened
The stock price of Ocugen Inc (NASDAQ: OCGN) increased by 2.12% yesterday. This is why it happened. ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. - O...
NEW YORK, June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN). Such investors are advised to contact Robert S. ...
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess o...
NEW YORK, June 15, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) resulting from allegations that Ocugen ... ...
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership. ...
Why Ocugen Stock Rallied Today
The biotech is bolstering its production capabilities for an experimental coronavirus vaccine. ...
The Motley Fool
Options Traders Speculate on OCGN After Vaccine Update
The shares of biopharmaceutical concern Ocugen Inc (NASDAQ:OCGN) are surging this afternoon, last seen up 7.2% to trade at $6.56. ...
Ocugen Stock Jumps After Recruiting Jubilant HollisterStier As Manufacturing Partner For COVID-19 Va...
Ocugen Inc (NASDAQ: OCGN) has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVID-19 vaccine candidate, Covaxin for the U.S. and Canadian markets. "Securing US-based manufacturing capability is a critical st... ...